Related Experiment Video
Updated: Aug 12, 2026

Psychophysical Tracking Method to Measure Taste Preferences in Children and Adults
Published on: July 16, 2016
Sweet Syndrome: A Review of Published Cases
Victoria Edlyne Orfaly1, Hadir Shakshouk2,3, Micheal Heath2
1Department of Dermatology, Oregon Health and Science University, Portland, Oregon, USA, orfaly@ohsu.edu.
Abstract:
Sweet syndrome (SS), the prototypical neutrophilic dermatosis, is characterized by abrupt onset of tender plaques and nodules, classically accompanied by fever and leukocytosis. While management mainly relies on systemic corticosteroids, inadequate response can be seen in some patients that necessitates exploring other treatment options. Early diagnosis of malignancy-associated SS (MA-SS) along with detection of concomitant malignancy is crucial for improving patients' outcomes. Data regarding various clinical manifestations, extracutaneous associations, treatment, and outcomes are poorly characterized in the literature. We aimed to review all published case reports and case series to portray clinical features of SS including extracutaneous manifestations. We also describe reported treatment options and their outcomes to draw attention toward unmet therapeutic needs in the management of SS. In addition, for clinical and practical purposes, we attempted to delineate the distinction between MA-SS and nonmalignant subtypes of SS.
Related Concept Videos
Synaptic Signaling
Sex-linked Disorders
Case Studies
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Acute Coronary Syndrome I: Introduction
Cushing Syndrome I: Introduction

